Funding offered for Cushing’s and Insulin Resistance research

The Equine Cushing's and Insulin Resistance Group Inc. (ECIR Group) is now accepting funding requests for 2024. These proposals should focus on researching Equine Metabolic Syndrome/Insulin Resistance (EMS/IR) and Pituitary Pars Intermedia Dysfunction (PPID). 

The ECIR Group's mission is to improve the well-being of equines with metabolic disorders through a blend of basic research and practical clinical experience. Their primary objective is to prevent laminitis. 

 

"Quality scientific research is critical to the continuous advancement of knowledge to benefit metabolic equines." said Dr. Kathleen Gustafson, ECIR Group Inc. Research Director. "Our goal in 2024 is to fund research and encourage collaboration between scientists, scholars, veterinarians, and hoof care professionals to positively affect the health and welfare of these equines."

 

"Through the sharing of their in-the-barn experience, ECIR Group supporters have helped build effective protocols for metabolically challenged equines." said current President, Nancy Collins. "It is an honor that now, through member financial support, the ECIR Group has expanded to also fund equine metabolic research."

 

Proposals seeking funding should focus on EMS and PPID, covering topics such as diagnosis, diet, hoof care, exercise (referred to as DDT/E) and preventing laminitis. Any proposals meeting these criteria will be considered.

 

Applications must be submitted via the ecirhorse.org research portal. Deadline for submission is May 31, 2024.

 

Researchers will find more information at https://www.ecirhorse.org/research-proposals.php